Metformin Reverses Prostate Cancer Resistance to Enzalutamide by Targeting TGF-β1/STAT3 Axis-Regulated EMT.
2017
Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF- β 1/STAT3 axis-regulated EMT
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
49
References
53
Citations
NaN
KQI